![David Szekeres](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Szekeres
President at
CONNECT BIOPHARMA HOLDINGS LIMITED
Net worth: 237 313 $ as of 30/09/2026
Profile
David L.
Szekeres currently serves as Executive Chairman at Annai Systems, Inc. since 2014, Chairman at GRI Bio, Inc. since 2023, Director at the Association of Corporate Counsel since 2010, Director at Anochi Biopharma, Inc. since 2011, Director at Animantis LLC, Director at CureMatch, Inc., Director at Colossal Biosciences, Inc., Trustee at Sanford Burnham Prebys Medical Discovery Institute, and President at Connect Biopharma Holdings Ltd. since 2024.
Former roles include Chairman at Vallon Pharmaceuticals, Inc., Director at Edico Genome Corp.
from 2014 to 2018, Attorney at Latham & Watkins LLP from 2006 to 2008, Attorney at O'Melveny & Myers LLP from 2001 to 2003, Senior Associate at Robertson Stephens, Inc. in 2000, CFO, Secretary, CAO & General Counsel at Regulus Therapeutics, Inc. in 2015, Head-Mergers & Acquisitions, Governance at Life Technologies Corp.
from 2008 to 2014, and Chief Legal, Business & Administrative Officer at Heron Therapeutics, Inc. from 2019 to 2020.
Education includes graduate degree from Duke University in 2000 and undergraduate degree from the University of California, Irvine in 1997.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 26/03/2026 | 215,739 ( 0.39% ) | 237 313 $ | 30/09/2026 | |
GRI BIO, INC. -.--% | 15/09/2026 | 0 ( -.--% ) | - $ | 30/09/2026 |
David Szekeres active positions
| Companies | Position | Start |
|---|---|---|
| GRI BIO, INC. | Chairman | 24/04/2023 |
| CONNECT BIOPHARMA HOLDINGS LIMITED | President | 12/06/2024 |
Colossal Biosciences, Inc.
 Colossal Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Colossal Biosciences, Inc. is a biotechnology company specializing in de-extinction and conservation through advanced genetic engineering technologies, including CRISPR. The company is based in Austin, TX and has subsidiaries in the United States. The company focuses on restoring extinct species, such as the woolly mammoth, and enhancing biodiversity to stabilize ecosystems. Colossal engineers climate-adapted versions of extinct megafauna to rewild habitats, address biodiversity loss, and tackle environmental challenges like climate change, carbon capture, and ecosystem degradation. The company operates state-of-the-art laboratories and integrates approaches spanning ancient DNA research, AI, machine learning, embryology, and stem cell biology. Colossal develops spin-off technologies for drug discovery, environmental remediation, sustainable agriculture, and plastic biodegradation. The company was founded by Ben Lamm, George McDonald Church. Ben Lamm has been the CEO since incorporation. | Director/Board Member | - |
CureMatch, Inc.
 CureMatch, Inc. Packaged SoftwareTechnology Services Develops combination therapy software system for decision support in personalized cancer medicine | Director/Board Member | - |
Animantis LLC
 Animantis LLC Packaged SoftwareTechnology Services Develops and applies computational tools to characterize cellular functions | Director/Board Member | - |
Sanford Burnham Prebys Medical Discovery Institute
 Sanford Burnham Prebys Medical Discovery Institute Medical/Nursing ServicesHealth Services Conducts medical research | Director/Board Member | - |
Association of Corporate Counsel
 Association of Corporate Counsel Miscellaneous Commercial ServicesCommercial Services Operates as a business professionals association | Director/Board Member | 01/02/2010 |
Anochi Biopharma, Inc. | Director/Board Member | 01/03/2011 |
Annai Systems, Inc.
 Annai Systems, Inc. Information Technology ServicesTechnology Services Provides technological services for genomic research and medicine | Chairman | - |
Former positions of David Szekeres
| Companies | Position | End |
|---|---|---|
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Education of David Szekeres
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
86
1st degree connections
19
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 19 |
|---|---|
Heron Therapeutics, Inc.
 Heron Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and commercializes of polymer technologies | Health Technology |
Annai Systems, Inc.
Annai Systems, Inc. Information Technology ServicesTechnology Services Provides technological services for genomic research and medicine | Technology Services |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
O'Melveny & Myers LLP
 O'Melveny & Myers LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Latham & Watkins LLP
 Latham & Watkins LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
University of California, Irvine
 University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Robertson Stephens, Inc.
 Robertson Stephens, Inc. Investment Banks/BrokersFinance Brokerage | Finance |
Association of Corporate Counsel
Association of Corporate Counsel Miscellaneous Commercial ServicesCommercial Services Operates as a business professionals association | Commercial Services |
Sanford Burnham Prebys Medical Discovery Institute
Sanford Burnham Prebys Medical Discovery Institute Medical/Nursing ServicesHealth Services Conducts medical research | Health Services |
Regulus Therapeutics, Inc.
 Regulus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in discovering and developing of drugs | Health Technology |
Life Technologies Corp.
 Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Edico Genome Corp.
 Edico Genome Corp. SemiconductorsElectronic Technology Develops bioinformatics processor chip that helps in DNA analysis | Electronic Technology |
Anochi Biopharma, Inc. | |
CureMatch, Inc.
CureMatch, Inc. Packaged SoftwareTechnology Services Develops combination therapy software system for decision support in personalized cancer medicine | Technology Services |
Animantis LLC
Animantis LLC Packaged SoftwareTechnology Services Develops and applies computational tools to characterize cellular functions | Technology Services |
Vallon Pharmaceuticals, Inc.
 Vallon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes proprietary biopharmaceutical products | Health Technology |
Connect Biopharma Holdings Ltd.
 Connect Biopharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Colossal Biosciences, Inc.
Colossal Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Colossal Biosciences, Inc. is a biotechnology company specializing in de-extinction and conservation through advanced genetic engineering technologies, including CRISPR. The company is based in Austin, TX and has subsidiaries in the United States. The company focuses on restoring extinct species, such as the woolly mammoth, and enhancing biodiversity to stabilize ecosystems. Colossal engineers climate-adapted versions of extinct megafauna to rewild habitats, address biodiversity loss, and tackle environmental challenges like climate change, carbon capture, and ecosystem degradation. The company operates state-of-the-art laboratories and integrates approaches spanning ancient DNA research, AI, machine learning, embryology, and stem cell biology. Colossal develops spin-off technologies for drug discovery, environmental remediation, sustainable agriculture, and plastic biodegradation. The company was founded by Ben Lamm, George McDonald Church. Ben Lamm has been the CEO since incorporation. | Commercial Services |
GRI Bio, Inc.
 GRI Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of inflammatory, fibrotic and autoimmune diseases | Health Technology |
- Stock Market
- Insiders
- David Szekeres
